The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gastrointestinal Cancer Devices-Global Market Insights and Sales Trends 2025
Synopsis
Gastrointestinal cancer is the malignant condition that affects the gastrointestinal tract and the digestive system. This includes cancers of the liver, small intestine, esophagus, gall bladder, pancreas, anus, stomach, and bowel.
The global Gastrointestinal Cancer Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Gastrointestinal Cancer Devices in various end use industries. The expanding demands from the Hospitals, Clinics, Specialized Cancer Treatment Centers and Ambulatory Surgical Centers, are propelling Gastrointestinal Cancer Devices market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Targeted Drugs Therapy segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Gastrointestinal Cancer Devices market, driven by demand from China, the second largest economy with some signs of stabilising, the Gastrointestinal Cancer Devices market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gastrointestinal Cancer Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gastrointestinal Cancer Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gastrointestinal Cancer Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gastrointestinal Cancer Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gastrointestinal Cancer Devices covered in this report include Eli Lilly, Roche, GlaxoSmithKline, Merck, Novartis, Otsuka Holdings, Stryker Corporation, Boston Scientific Corporation and Johnson & Johnson, etc.
The global Gastrointestinal Cancer Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Roche
GlaxoSmithKline
Merck
Novartis
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson & Johnson
CONMED Corporation.
Global Gastrointestinal Cancer Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gastrointestinal Cancer Devices market, Segment by Type:
Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy
Global Gastrointestinal Cancer Devices market, by Application
Hospitals
Clinics
Specialized Cancer Treatment Centers
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gastrointestinal Cancer Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gastrointestinal Cancer Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Gastrointestinal cancer is the malignant condition that affects the gastrointestinal tract and the digestive system. This includes cancers of the liver, small intestine, esophagus, gall bladder, pancreas, anus, stomach, and bowel.
The global Gastrointestinal Cancer Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Gastrointestinal Cancer Devices in various end use industries. The expanding demands from the Hospitals, Clinics, Specialized Cancer Treatment Centers and Ambulatory Surgical Centers, are propelling Gastrointestinal Cancer Devices market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Targeted Drugs Therapy segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Gastrointestinal Cancer Devices market, driven by demand from China, the second largest economy with some signs of stabilising, the Gastrointestinal Cancer Devices market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gastrointestinal Cancer Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gastrointestinal Cancer Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gastrointestinal Cancer Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gastrointestinal Cancer Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gastrointestinal Cancer Devices covered in this report include Eli Lilly, Roche, GlaxoSmithKline, Merck, Novartis, Otsuka Holdings, Stryker Corporation, Boston Scientific Corporation and Johnson & Johnson, etc.
The global Gastrointestinal Cancer Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Roche
GlaxoSmithKline
Merck
Novartis
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson & Johnson
CONMED Corporation.
Global Gastrointestinal Cancer Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gastrointestinal Cancer Devices market, Segment by Type:
Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy
Global Gastrointestinal Cancer Devices market, by Application
Hospitals
Clinics
Specialized Cancer Treatment Centers
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gastrointestinal Cancer Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gastrointestinal Cancer Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Gastrointestinal Cancer Devices Market Overview
1.1 Gastrointestinal Cancer Devices Product Overview
1.2 Gastrointestinal Cancer Devices Market Segment by Type
1.2.1 Surgery
1.2.2 Targeted Drugs Therapy
1.2.3 Chemo Therapy
1.2.4 Adjuvant Chemotherapy
1.2.5 Radiation Therapy
1.3 Global Gastrointestinal Cancer Devices Market Size by Type
1.3.1 Global Gastrointestinal Cancer Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Gastrointestinal Cancer Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Gastrointestinal Cancer Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gastrointestinal Cancer Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Gastrointestinal Cancer Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Gastrointestinal Cancer Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Gastrointestinal Cancer Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Gastrointestinal Cancer Devices Sales Breakdown by Type (2018-2023)
2 Global Gastrointestinal Cancer Devices Market Competition by Company
2.1 Global Top Players by Gastrointestinal Cancer Devices Sales (2018-2023)
2.2 Global Top Players by Gastrointestinal Cancer Devices Revenue (2018-2023)
2.3 Global Top Players by Gastrointestinal Cancer Devices Price (2018-2023)
2.4 Global Top Manufacturers Gastrointestinal Cancer Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gastrointestinal Cancer Devices Market Competitive Situation and Trends
2.5.1 Gastrointestinal Cancer Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Gastrointestinal Cancer Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Gastrointestinal Cancer Devices Market
2.8 Key Manufacturers Gastrointestinal Cancer Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gastrointestinal Cancer Devices Status and Outlook by Region
3.1 Global Gastrointestinal Cancer Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Gastrointestinal Cancer Devices Historic Market Size by Region
3.2.1 Global Gastrointestinal Cancer Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Gastrointestinal Cancer Devices Sales in Value by Region (2018-2023)
3.2.3 Global Gastrointestinal Cancer Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Gastrointestinal Cancer Devices Forecasted Market Size by Region
3.3.1 Global Gastrointestinal Cancer Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Gastrointestinal Cancer Devices Sales in Value by Region (2024-2029)
3.3.3 Global Gastrointestinal Cancer Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Gastrointestinal Cancer Devices by Application
4.1 Gastrointestinal Cancer Devices Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Specialized Cancer Treatment Centers
4.1.4 Ambulatory Surgical Centers
4.2 Global Gastrointestinal Cancer Devices Market Size by Application
4.2.1 Global Gastrointestinal Cancer Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Gastrointestinal Cancer Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Gastrointestinal Cancer Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gastrointestinal Cancer Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Gastrointestinal Cancer Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Gastrointestinal Cancer Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Gastrointestinal Cancer Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Gastrointestinal Cancer Devices Sales Breakdown by Application (2018-2023)
5 North America Gastrointestinal Cancer Devices by Country
5.1 North America Gastrointestinal Cancer Devices Historic Market Size by Country
5.1.1 North America Gastrointestinal Cancer Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Gastrointestinal Cancer Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Gastrointestinal Cancer Devices Sales in Value by Country (2018-2023)
5.2 North America Gastrointestinal Cancer Devices Forecasted Market Size by Country
5.2.1 North America Gastrointestinal Cancer Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Gastrointestinal Cancer Devices Sales in Value by Country (2024-2029)
6 Europe Gastrointestinal Cancer Devices by Country
6.1 Europe Gastrointestinal Cancer Devices Historic Market Size by Country
6.1.1 Europe Gastrointestinal Cancer Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Gastrointestinal Cancer Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Gastrointestinal Cancer Devices Sales in Value by Country (2018-2023)
6.2 Europe Gastrointestinal Cancer Devices Forecasted Market Size by Country
6.2.1 Europe Gastrointestinal Cancer Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Gastrointestinal Cancer Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Gastrointestinal Cancer Devices by Region
7.1 Asia-Pacific Gastrointestinal Cancer Devices Historic Market Size by Region
7.1.1 Asia-Pacific Gastrointestinal Cancer Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Gastrointestinal Cancer Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Gastrointestinal Cancer Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Gastrointestinal Cancer Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Gastrointestinal Cancer Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Gastrointestinal Cancer Devices Sales in Value by Region (2024-2029)
8 Latin America Gastrointestinal Cancer Devices by Country
8.1 Latin America Gastrointestinal Cancer Devices Historic Market Size by Country
8.1.1 Latin America Gastrointestinal Cancer Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Gastrointestinal Cancer Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Gastrointestinal Cancer Devices Sales in Value by Country (2018-2023)
8.2 Latin America Gastrointestinal Cancer Devices Forecasted Market Size by Country
8.2.1 Latin America Gastrointestinal Cancer Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Gastrointestinal Cancer Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Gastrointestinal Cancer Devices by Country
9.1 Middle East and Africa Gastrointestinal Cancer Devices Historic Market Size by Country
9.1.1 Middle East and Africa Gastrointestinal Cancer Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Gastrointestinal Cancer Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Gastrointestinal Cancer Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Gastrointestinal Cancer Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Gastrointestinal Cancer Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Gastrointestinal Cancer Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Information
10.1.2 Eli Lilly Introduction and Business Overview
10.1.3 Eli Lilly Gastrointestinal Cancer Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Eli Lilly Gastrointestinal Cancer Devices Products Offered
10.1.5 Eli Lilly Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Gastrointestinal Cancer Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Roche Gastrointestinal Cancer Devices Products Offered
10.2.5 Roche Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Gastrointestinal Cancer Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Gastrointestinal Cancer Devices Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Gastrointestinal Cancer Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Gastrointestinal Cancer Devices Products Offered
10.4.5 Merck Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Gastrointestinal Cancer Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis Gastrointestinal Cancer Devices Products Offered
10.5.5 Novartis Recent Development
10.6 Otsuka Holdings
10.6.1 Otsuka Holdings Company Information
10.6.2 Otsuka Holdings Introduction and Business Overview
10.6.3 Otsuka Holdings Gastrointestinal Cancer Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Otsuka Holdings Gastrointestinal Cancer Devices Products Offered
10.6.5 Otsuka Holdings Recent Development
10.7 Stryker Corporation
10.7.1 Stryker Corporation Company Information
10.7.2 Stryker Corporation Introduction and Business Overview
10.7.3 Stryker Corporation Gastrointestinal Cancer Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Stryker Corporation Gastrointestinal Cancer Devices Products Offered
10.7.5 Stryker Corporation Recent Development
10.8 Boston Scientific Corporation
10.8.1 Boston Scientific Corporation Company Information
10.8.2 Boston Scientific Corporation Introduction and Business Overview
10.8.3 Boston Scientific Corporation Gastrointestinal Cancer Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Boston Scientific Corporation Gastrointestinal Cancer Devices Products Offered
10.8.5 Boston Scientific Corporation Recent Development
10.9 Johnson & Johnson
10.9.1 Johnson & Johnson Company Information
10.9.2 Johnson & Johnson Introduction and Business Overview
10.9.3 Johnson & Johnson Gastrointestinal Cancer Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Johnson & Johnson Gastrointestinal Cancer Devices Products Offered
10.9.5 Johnson & Johnson Recent Development
10.10 CONMED Corporation.
10.10.1 CONMED Corporation. Company Information
10.10.2 CONMED Corporation. Introduction and Business Overview
10.10.3 CONMED Corporation. Gastrointestinal Cancer Devices Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CONMED Corporation. Gastrointestinal Cancer Devices Products Offered
10.10.5 CONMED Corporation. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gastrointestinal Cancer Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gastrointestinal Cancer Devices Industrial Chain Analysis
11.4 Gastrointestinal Cancer Devices Market Dynamics
11.4.1 Gastrointestinal Cancer Devices Industry Trends
11.4.2 Gastrointestinal Cancer Devices Market Drivers
11.4.3 Gastrointestinal Cancer Devices Market Challenges
11.4.4 Gastrointestinal Cancer Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gastrointestinal Cancer Devices Distributors
12.3 Gastrointestinal Cancer Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
